US Patent Issued to CatalYm, JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG on Dec. 16 for "Anti-GDF15 antibody and a dosage regimen for the treatment of cancer" (German, Swiss Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,447, issued on Dec. 16, was assigned to CatalYm GmbH (Planegg-Martinsried, Germany) and JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG (Wurzburg, Germany).

"Anti-GDF15 antibody and a dosage regimen for the treatment of cancer" was invented by Eugen Leo (Munich), Markus Haake (Estenfeld, Germany), Jorg Wischhusen (Wurzburg, Germany), Virginie Le Brun (Basel, Switzerland), Susanne Jorg (Basel, Switzerland) and Manfred Rudiger (Planegg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an anti-GDF15 antibody and to a dosage regimen for the treatment of cancer in a human patient using the anti-GDF15 antibody. The present i...